Literature DB >> 32886364

COVID-19 and systemic therapies in psoriasis: experience of a tertiary hospital in Madrid.

Jon Fulgencio-Barbarin1, Mario Puerta-Peña1, Pablo Ortiz-Romero1, Carmen García-Donoso1, Raquel Rivera-Diaz1.   

Abstract

Entities:  

Year:  2020        PMID： 32886364     DOI： 10.1111/ijd.15157

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  2 in total

1.  COVID-19 and biologic therapies in dermatology: seroprevalence survey and severity analysis in a tertiary hospital in Spain.

Authors:  Leire Barrutia; Victor Volo; Daniel Ruíz-Sánchez; Jara Valtueña; Angel Aguado García; Pilar Manchado López
Journal:  Int J Dermatol       Date:  2021-02-09       Impact factor: 3.204

Review 2.  Biologics for Psoriasis during the COVID-19 Pandemic.

Authors:  Koji Kamiya; Mayumi Komine; Mamitaro Ohtsuki
Journal:  J Clin Med       Date:  2021-03-30       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.